| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1949009 | Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2016 | 9 Pages |
Abstract
Taken together, our study shows that SCD1 is a key player in the development of AFLD and associated deleterious effects, and suggests SCD1 inhibition as a therapeutic option for the treatment of this hepatic disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Mohamed A. Lounis, Quentin Escoula, Cathy Veillette, Karl-F. Bergeron, James M. Ntambi, Catherine Mounier,